Qualigen Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Qualigen Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4% to $5,204,755. The net income raised on -$13,417,212 and profit margin reached -258%. Total operating expenses were $6,095,607.
Profit Margin
| 2014 | 0 | -2.47M | |
|---|---|---|---|
| 2015 | 0 | -9.17M | |
| 2016 | 0 | -18.38M | |
| 2017 | 9.77M | -7.86M | -80.44% |
| 2018 | 5.80M | -1.20M | -20.69% |
| 2020 | 4.30M | -20.41M | -474.16% |
| 2021 | 5.65M | -17.89M | -316.55% |
| 2022 | 4.98M | -21.03M | -422.08% |
| 2023 | 5.20M | -13.41M | -257.79% |
QLGN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 5.20M | 4.98M | 5.65M | 4.30M | 5.80M | 9.77M | 0 | 0 | 0 |
Cost of revenue | 5.20M | 4.30M | 4.33M | 7.18M | 5.42M | 7.90M | 18.44M | 8.90M | 3.47K |
Gross profit | -4.49K | 680.80K | 1.32M | -2.87M | 378.39K | 1.87M | -18.44M | -8.90M | -3.47K |
Operating exp. | |||||||||
Research and development | 5.20M | 6.83M | 11.71M | 3.55M | 1.31M | 2.87M | 13.29M | 2.26M | 113.93K |
Selling and marketing | -4.49K | 950.42K | 542.59K | 400.16K | 380.34K | 618.46K | 0 | 0 | 0 |
Total operating expenses | 6.09M | 18.62M | 23.98M | 17.40M | 1.42M | 7.65M | 18.17M | 8.66M | 2.27M |
Operating income | -11.30M | -17.94M | -22.66M | -11.30M | -1.05M | -15.55M | -36.62M | -17.57M | -2.28M |
Other income (expenses), net | -1.17M | -3.35M | 4.77M | -7.74M | -140.54K | 38.6K | 18.23M | 8.78M | -191.84K |
Income before tax | -12.47M | -21.29M | -17.89M | -20.41M | -1.19M | -7.86M | -18.38M | -9.17M | -2.47M |
Income tax expense | -4.79K | -265.07K | 5.42K | 619 | 4.61K | 5.08K | 0 | -1.93K | 1 |
Net income | -13.41M | -21.03M | -17.89M | -20.41M | -1.20M | -7.86M | -18.38M | -9.17M | -2.47M |
Earnings per share | |||||||||
Basic EPS | -2.46 | -5.48 | -6.1 | -28.21 | -2.26 | -14.04 | -20.44 | -31.15 | -794 |
Diluted EPS | -2.46 | -5.48 | -6.1 | -28.21 | -2.26 | -14.04 | -20.44 | -31.15 | -794 |
| Data source | Data source | Data source | Data source | Data source | Data source |